Core Insights - Aurora Cannabis Inc. (NASDAQ: ACB) is recognized as one of the best cannabis stocks to invest in currently [1][2] - Canaccord has reduced its price target for Aurora Cannabis from C$10 to C$9 while maintaining a Buy rating [2] Financial Performance - In Q3 of fiscal 2026, Aurora Cannabis reported a 7% year-over-year growth in total net sales, reaching $94.2 million [3] - Medical cannabis net sales in Germany and Poland increased by 12% to a record $76.2 million [3] - The company achieved free cash flow of $15.5 million, adjusted net income of $7.2 million, and adjusted EBITDA of $18.5 million [3] - At the end of the quarter, Aurora Cannabis announced a debt-free status with $154.4 million in cash and short-term investments [3] Business Operations - Aurora Cannabis operates through its Plant Propagation and Cannabis divisions, focusing on the production, distribution, and sale of cannabis and cannabis-derived products [4] - The management emphasizes leadership in genetics, GMP production, global medicinal cannabis, operational efficiency, regulatory knowledge, and potential M&A opportunities [3]

Group 1 - Canopy Growth Corporation (NASDAQ:CGC) is recognized as one of the best cannabis stocks to invest in currently [1] - Alliance Global has reduced its price target for Canopy Growth from C$2.50 to C$1.80 while maintaining a Neutral rating, reflecting concerns over veteran reimbursement changes and gross margin uncertainties [2] - The company reported a fiscal third-quarter loss of C$0.18 per share, an improvement from a loss of C$1.11 per share in the same quarter last year, with revenue increasing from C$86.24 million to C$90.39 million [3] Group 2 - Canopy Growth operates in multiple segments including Canada Cannabis, International Markets Cannabis, Storz and Bickel, This Works, and Other [4] - The management highlighted ongoing efforts to enhance operational execution and mentioned the acquisition of MTL Cannabis as a strategic move to strengthen the company's platform [3]

Core Insights - Organigram Global Inc. (NASDAQ:OGI) is recognized as one of the top cannabis stocks to invest in currently [1] - The company reported Q1 revenue of $97.3 million, surpassing the consensus estimate of $73.15 million, with an adjusted EBITDA of $5.3 million, up from $1.4 million year-over-year [2] - The growth in revenue and profits is attributed to higher flower yields, synergies from the Motif integration, increased international sales, and improved operational efficiency [2] - Canaccord initiated coverage of OGI with a price target of C$3 and a Buy rating, highlighting the Canadian cannabis market as a global benchmark despite existing challenges [3] Financial Performance - Q1 revenue reached $97.3 million, exceeding the consensus of $73.15 million [2][7] - Adjusted EBITDA increased to $5.3 million from $1.4 million in the previous year, indicating significant profit growth [2] Market Position and Strategy - Organigram is a market leader in pre-rolls, extracts, and milled flower, and is transitioning to a globally integrated, vertically integrated cannabis corporation [3] - The company aims to expand its global presence through international business alliances [4]

Industry Overview - The cannabis industry is expected to see significant changes by 2026, with potential for increased momentum in marijuana stocks due to U.S. federal reform aimed at improving profitability among leading operators [1] - Expanding international medical markets are also anticipated to play a crucial role for investors in the cannabis sector [1] Market Dynamics - Global partnerships between different cannabis markets are emerging as a key trend, suggesting selective but compelling investment opportunities for informed investors [2] - Staying updated on trends and company developments is essential for determining the performance of individual marijuana stocks [2] Investment Strategy - Despite the volatility in the cannabis sector, the potential rewards may justify the risks, with 2026 seen as a transitional year from speculative hype to fundamental value creation [3] - Investors who focus on regulatory awareness, financial analysis, and strategic diversification will be well-positioned to benefit from the next growth phase in marijuana stocks [3] Company Highlights - **Planet 13 Holdings Inc.** has exited the California cannabis market as of February 12, 2026, to concentrate on other growth markets, reflecting a strategic decision to streamline operations [7][8] - **Jushi Holdings Inc.** has opened a new Beyond Hello™ location in Ohio, marking its second retail outlet in Cincinnati, which is part of its strategic growth plan in the state [10][11]

Vancouver, British Columbia--(Newsfile Corp. - February 13, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to announce expansion of its Commercial Partners ProgramTM to support global market growth, through completion of an initial softgel shipment to Australia.Nextleaf Announces Initial Softgel Shipment to AustraliaIn January 2026 Nextleaf served as exporter of ...

Core Viewpoint - cbdMD, Inc. will host a conference call on February 17, 2026, to discuss its financial results for the first quarter ending December 31, 2025, and business progress [1]. Company Overview - cbdMD, Inc. is a leading and highly trusted CBD company, recognized for its comprehensive line of U.S. produced THC-free CBD products and Farm Act compliant Delta 9 products [1]. - The company offers a range of brands, including Paw CBD for pet products, ATRx for functional mushroom products, and Herbal Oasis, a THC-infused social seltzer [1]. - Herbal Oasis is designed to provide a fast-acting, functional beverage that promotes clarity, balance, and joy, featuring an alcohol-free formula and wellness-forward ingredients [1]. Conference Call Details - The conference call is scheduled for February 17, 2026, at 4:20 p.m. Eastern Time, with a dial-in number for USA/Canada participants being 888-880-3330 [1]. - A webcast replay of the conference call will be available until February 17, 2027 [1].

RT Will Yakowicz (@WillYakowicz)It's time for entrepreneurs to apply to the@Forbes Cannabis 42.0 List. If you have built a successful, privately-owned company in legal weed, please apply here: https://t.co/rEILv76KRz https://t.co/4rmjvCqT7U ...

Core Insights - Jeremy Szafron has joined Kitco News as an anchor and producer, bringing extensive experience in journalism, particularly in finance and current affairs [1][5] Background and Experience - Jeremy began his journalism career in 2006 at CTV, initially focusing on entertainment before transitioning to business reporting, especially in mining and small-cap sectors [2] - He gained recognition for his macro-financial and market trends analysis, becoming a sought-after commentator on CTV Morning Live and a regular on CTV News Network [2] - A significant highlight of his career was covering the 2010 Vancouver Olympic Games, which led to the development of an online video news program for PressReader, a digital newsstand with 8,000 editions in 60 languages [3] Digital Media Ventures - In 2012, Jeremy launched The Green Scene Podcast, which quickly attracted over 400,000 subscribers, establishing him as a prominent voice in the cannabis industry [4] - Following this success, he created Investor Scene and Initiate Research, platforms that provide exclusive market insights and deal-flow opportunities in mining and Canadian small-cap markets [4] Professional Roles - Jeremy has served as a market strategist and investor relations consultant for various publicly traded companies across mining, energy, consumer packaged goods (CPG), and technology sectors [5] - He holds a BA in Journalism from Concordia University, which has supported his diverse career trajectory [5]

Core Insights - Planet 13 Holdings Inc. has successfully completed the divestiture of its retail and distribution licenses in Orange County, California, and has sold its cultivation facility property in Coalinga, California, marking a significant step in its exit from the California market [1][2] Group 1: Strategic Focus - The divestiture aligns with Planet 13's strategic priority to exit California during the 2025–2026 period and to reallocate capital and management focus towards higher-return markets, particularly Nevada and Florida [2][3] - The closure of retail and distribution operations simplifies the company's operating footprint and strengthens its balance sheet and liquidity profile [2][3] Group 2: Operational Impact - The exit from California, which historically contributed a small portion of consolidated revenue and was cash-flow negative, is expected to reduce operating complexity and overhead [3] - Management can now concentrate resources on expansion and operational excellence in core markets, enhancing overall operational focus and capital allocation [3] Group 3: Company Overview - Planet 13 is a vertically integrated cannabis company with operations in Nevada, Illinois, and Florida, known for its award-winning cultivation and production [4] - The company operates the largest dispensary in the U.S. located in Las Vegas and has recently expanded its footprint with new locations and a consumption lounge [4]

Core Viewpoint - Cannara Biotech Inc. is set to host an investor webcast presentation on February 19, 2026, to discuss key aspects of its business and engage with investors through a Q&A session [1][2]. Company Overview - Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis products at affordable prices, operating two mega facilities in Québec that cover over 1,600,000 square feet [1][3]. - The company has the potential for an annualized cultivation output of 100,000 kg, leveraging Québec's low electricity costs to maintain affordability [3].